Skip to main content

IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES

Generic: IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES

Verified·Apr 23, 2026
Manufacturer
Sebela
NDC
52187-545
RxCUI
1191376
Route
TOPICAL
ICD-10 indication
L30.3

Affordability Check

How much will you actually pay for IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES?

In 30 seconds, see every legitimate way to afford IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES

What is this medication? This prescription medication is a topical combination treatment used to manage various skin conditions that involve inflammation and potential infection. It contains iodoquinol, which acts as an antifungal and antibacterial agent to help eliminate harmful microorganisms on the skin. Hydrocortisone acetate is a mild corticosteroid included to reduce redness, swelling, and itching. The aloe polysaccharides component is derived from the aloe vera plant and is used to soothe the skin and provide a protective barrier during the healing process.

Doctors primarily prescribe this medication for dermatological issues such as eczema, dermatitis, or other types of skin rashes that are complicated by a fungal or bacterial presence. By addressing both the infection and the inflammatory symptoms simultaneously, the cream or gel helps to provide relief while clearing the skin. It is intended only for external use on the skin and should be applied according to the specific instructions provided by a healthcare professional to ensure safe and effective treatment.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES. Official source: DailyMed (NLM) · Label effective Nov 4, 2024

Indications and usage
INDICATIONS: Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: “Possibly” Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); monliasis; intertrigo. Final classification of the less-than-effective indications requires further investigation.
Dosage and administration
DOSAGE AND ADMINISTRATION: Apply to affected area(s) three to four times per day or as directed by a physician. Follow your physician’s directions regarding length of treatment after symptoms resolve.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.
Warnings
WARNINGS: KEEP OUT OF REACH OF CHILDREN.
Adverse reactions
ADVERSE REACTIONS: The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.